Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Franz

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|June 4, 2015
Acute pontine infarction after percutaneous coronary intervention: a very rare but devastating complicationF Arslan, J Mair, W-M Franz, et al.
Clinical Chemistry|February 1, 1996
Serum troponin T: diagnostic marker for acute myocarditisW M Franz, A Remppis, R Kandolf, et al.
Internal Medicine Journal|July 30, 2015
Mobilisation of haemopoietic stem cells in teriparatide-treated patientsU Grabmaier, B C Huber, W-M Franz, et al.
Gene Therapy|October 1, 1996
Heart muscle-specific gene expression using replication defective recombinant adenovirusT Rothmann, H A Katus, R Hartong, et al.
Zeitschrift Fur Kardiologie|January 1, 1995
[A transgenic animal model: new possibilities for cardiovascular research]W M Franz, N Frey, O Müller, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 1, 1997
Transgenic animal models: new avenues in cardiovascular physiologyW M Franz, O J Mueller, R Hartong, et al.
Circulation Research|October 1, 1993
Heart-specific targeting of firefly luciferase by the myosin light chain-2 promoter and developmental regulation in transgenic miceW M Franz, D Breves, K Klingel, et al.
Clinical Genetics|November 3, 2010
Thromboembolism and coumarin overdosage in a 19-year-old female: impact of pharmacogeneticsC Brenner, B Huber, A Becker, et al.
Cardioscience|December 1, 1994
Characterization of a cardiac-selective and developmentally upregulated promoter in transgenic miceW M Franz, G Brem, H A Katus, et al.
Human Gene Therapy|September 19, 1998
Heart-specific targeting of beta-galactosidase by the ventricle-specific cardiac myosin light chain 2 promoter using adenovirus vectorsF Griscelli, P Gilardi-Hebenstreit, N Hanania, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|June 4, 2015
Acute pontine infarction after percutaneous coronary intervention: a very rare but devastating complicationF Arslan, J Mair, W-M Franz, et al.
Clinical Chemistry|February 1, 1996
Serum troponin T: diagnostic marker for acute myocarditisW M Franz, A Remppis, R Kandolf, et al.
Internal Medicine Journal|July 30, 2015
Mobilisation of haemopoietic stem cells in teriparatide-treated patientsU Grabmaier, B C Huber, W-M Franz, et al.
Gene Therapy|October 1, 1996
Heart muscle-specific gene expression using replication defective recombinant adenovirusT Rothmann, H A Katus, R Hartong, et al.
Zeitschrift Fur Kardiologie|January 1, 1995
[A transgenic animal model: new possibilities for cardiovascular research]W M Franz, N Frey, O Müller, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 1, 1997
Transgenic animal models: new avenues in cardiovascular physiologyW M Franz, O J Mueller, R Hartong, et al.
Circulation Research|October 1, 1993
Heart-specific targeting of firefly luciferase by the myosin light chain-2 promoter and developmental regulation in transgenic miceW M Franz, D Breves, K Klingel, et al.
Clinical Genetics|November 3, 2010
Thromboembolism and coumarin overdosage in a 19-year-old female: impact of pharmacogeneticsC Brenner, B Huber, A Becker, et al.
Cardioscience|December 1, 1994
Characterization of a cardiac-selective and developmentally upregulated promoter in transgenic miceW M Franz, G Brem, H A Katus, et al.
Human Gene Therapy|September 19, 1998
Heart-specific targeting of beta-galactosidase by the ventricle-specific cardiac myosin light chain 2 promoter using adenovirus vectorsF Griscelli, P Gilardi-Hebenstreit, N Hanania, et al.
Pageof 4